nacartocin: analog of oxytocin with enhanced natriuretic properties; RN given refers to (L-Phe)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6917772 |
| CHEMBL ID | 2218901 |
| MeSH ID | M0125142 |
| Synonym |
|---|
| nacartocin |
| 77727-10-7 |
| (2s)-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-1-[(4s,7s,10s,13s,16s)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2s)-butan-2-yl]-16-[(4-ethylphenyl)methyl]-6,9,12,15,18-pentaoxo-1-thia-5,8,11,14,17-pentazacycloicosane-4-ca |
| unii-ta88w10b8z |
| nacartocinum |
| nacartocina |
| ta88w10b8z , |
| nacartocinum [latin] |
| 1-(3-mercaptopropionic acid)-2-(3-(p-ethylphenyl)-l-alanine)-6-(l-2-aminobutyric acid)oxytocin |
| nacartocina [spanish] |
| nacartocine |
| 1-(3-marcaptopropionsaeure)-2-(3-(4-ethylphenyl)-l-alanin)-6-(l-2-aminobuttersaeure)oxytocin |
| nacartocine [french] |
| nacartocin [inn] |
| CHEMBL2218901 |
| glycinamide, n-(3-mercapto-1-oxopropyl)-l-tyrosyl-l-isoleucyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-leucyl-, cyclic (1->5)-disulfide |
| Q27289869 |
| DTXSID801024617 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||